Metadoxine ER: Phase IIb started

Alcobra began a double-blind, placebo-controlled Israeli Phase IIb trial to evaluate a single dose of 14-22 mg/kg oral MDX in up to 82 patients ages 13-17 years with predominantly inattentive ADHD. Th...